420 likes | 622 Views
Present by R2 Choopong Luansritisakul R2 Jittrawan Attawattanakul Supervise by Assoc.Prof . Sirilak Suksompong. Risk For MI After Arthroplasty. A 81 year-old man Admit for Elective total hip replacement Underlying disease : HT on Atenolol (50) 1x1
E N D
Present by R2 ChoopongLuansritisakul R2 JittrawanAttawattanakul Supervise by Assoc.Prof. SirilakSuksompong Risk For MI After Arthroplasty
A 81 year-old man • Admit for Elective total hip replacement • Underlying disease : HT on Atenolol (50) 1x1 DLP on Simvastatin (20) 1x1 Old CVA 4year ago (full recovery) Previous MI 11 months ago • Choice of anesthesia : GA with ETT • Intraoperative : no complication • POD 7 : typical angina , ECG CK-MB 2.7 (0-3ng/ml), Trop-T 1.78(0-0.2ng/ml) Imp NSTEMI
Acute Myocardial Infarction • Definition • Detection of and/or of cardiac biomarker values (preferably cardiac troponin) with > value above the 99th percentile upper reference limit and with > one of the following : Circulation, published online August 24,2012; 2012 American Heart Association,Inc.
Symptoms of ischemia • New or presumed new significant ST-T changes or new LBBB • Development of pathological Q waves in ECG • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality • Identification of an intracoronary thrombus by angiography or autopsy Circulation, published online August 24,2012; 2012 American Heart Association,Inc.
Postoperative Myocardial Infarction • Often recognized late (postoperative day 3 - 5), resulting in high (30% - 70%) mortality
Morbidity and Mortality Incidence From Anesthesiologist records in last year
Myocardial Infarction VS Total Hip or Knee Replacement
Limitation such as • small sample sizes • lack of matched control • only focused on short-term • no analysis for medication
Strengths • The nationwide population-based design • Large sample size • Information on matched controls • Completeness of follow-up
Nationwide matched control retrospective cohort study • The Danish national registries
Inclusion criteria • Patients who underwent a primary THR or TKR surgery • January,1998 to December, 2007 • Age 18 years or older
Exclusion criteria • Prior AMI within 6 weeks before
95,664 Patients 437 patients excluded THR group (n=66,524) Control group (n=200,001) TKR group (n=28,703) Control group (n=86,164) Thromboprophylaxis Thromboprophylaxis • Followed up until - Death • Migration • Revision THR or TKR • End of study period • Acute myocardial infarction
Incidence of acute myocardial infarction • Potential risk factors • Age • Sex • History of AMI, heart failure, cerebrovascular disease • Drug dispensing within 6 months
Baseline Characteristics of patients Undergoing THR and Matched control
Effect Modifiers of AMI risk after THR or TKR vs Matched controls Adjusted HR (6-wk risk for AMI)
Marrow Embolization Antithrombotic Agents
Limitations • Lack of information on other risk factors for AMI • smoking, blood pressure, biochemical variables, and BMI • No information on inpatient anticoagulant use • No information about GA or RA
GA vs RA • General anesthesia vs Regional anesthesia showed a trend toward only 1.4 fold increase risk of AMI Anesthesia for hip fracture surgery in adults (Review) 2004 The Cochrane Collaboration
Increase risk of AMI during the first 2 weeks after arthroplasty • AMI within 1 year should be contraindication for undergoing elective THR surgery
Prophylactic therapy • Adrenergic Blockers • Statins • Calcium channel Blockers • 2 Agonists • Aspirin
Prophylactic therapy • Adrenergic Blockers • Long term should not be discontinued • No study has compared prophylactic B-Blockade with short term
Prophylactic therapy • Adrenergic Blockers • Statins • Abrupt withdrawal cause plaque destabilization • Reduced perioperative and long term cardiac complication • Large randomized controlled trials are still needed
Perioperative Management • Correct tachycardia, hypertension, hypotension, and pain • Tight hemodynamic monitoring • Blood transfusion in patients with CAD and Hb<10 • Coronary intervention and antithrombotic therapy
Take Home Messages • New definition of AMI • THR and TKR patients increased risk of AMI during the first 2 weeks after surgery • Elective THR and TKR should be contraindicated in patients with previous MI in last 1 year before • Management for decrease risk of postoperative MI are necessary